OrbiMed Capital GP III LLC, 10% Owner at Roka BioScience, Inc. (ROKA), sold 401,335 shares at $0.68 ($273K) on 2017-10-03, disclosed to the SEC on 2017-10-05.
Open-market sale of $273k ROKA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.68 | 1,899 | $1K | 0.5% |
| 2 | $0.68 | 199,718 | $136K | 49.8% |
| 3 | $0.68 | 199,718 | $136K | 49.8% |
| Total | $0.68 avg | 401,335 | $273K | 100% |
| Filing → |
| VRAY | SELL | 2018-08-07 | $3.8M | — | Filing → |
| PIRS | SELL | 2018-02-15 | $141K | — | Filing → |
| PIRS | SELL | 2017-12-20 | $842K | — | Filing → |